ISRCTN ISRCTN38634580
DOI https://doi.org/10.1186/ISRCTN38634580
Secondary identifying numbers Diabetes FUUTA
Submission date
13/01/2014
Registration date
06/02/2014
Last edited
06/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Type 2 diabetes is an increasing problem in sub-Saharian Africa: the prevalence and burden are rising very quickly as a consequence of major changes in lifestyle. In 2009 the International Diabetes Federation projected a 98% growth in the number of diabetic adults in this region. The main cause of diabetes in Africa, as everywhere, is impaired glucose tolerance (IGT), when blood glucose is raised beyond the normal range but it is not so high that you have diabetes. It is a consequence of urbanization and changes in diet. In Senegal (West Africa) it is already a great public health problem in the main city (Dakar) and its suburbs. In the villages, with a very different way of life, it is still unknown. In our hospital in Saint-Die (France) we have found that the Senegalese migrants (in majority coming from Fuuta, the northern region along the Senegal river) have a very high prevalence of IGT or type 2 diabetes. The aim of this study was to compare the prevalence of abnormal glucose status between the Senegalese migrants in France, especially around Saint-Die, and their relatives living in their villages in Fuuta. Our objective is to find out whether migration can lead to an increase of prevalence of IGT or type 2 diabetes among Senegalese migrants.

Who can participate?
We studied adults of both sexes, older than 18 years, who had accepted to be tested. The study involved two different populations. First, a study was conducted in Senegalese migrants in Saint-Die (SD group). Second, we studied the adult population of five villages in Fuuta (F group).

What does the study involve?
For all the selected participants we recorded the sex and age and measured height, weight, body mass index (BMI), waist/hip ratio and blood sugar levels.

What are the possible benefits and risks of participating?
There were no risks for the subjects. If we discovered a participant had type 2 diabetes the participant was informed of this so they could be treated.

Where is the study run from?
Centre Hospitalier Saint-Charles à Saint-Dié-des-Vosges (France).

When is the study starting and how long is it expected to run for?
The study began in November 2000 and finished in November 2001.

Who is funding the study?
Association pour la Prévention de l’Obésité et du Diabète en Déodatie (APODD) (Saint-Die, France).

Who in the main contact?
Dr JM Dollet
jean-marc-dollet@wanadoo.fr

Contact information

Dr Jean-Marc Dollet
Scientific

Service de Médecine A
Centre Hospitalier Saint-Charles
Saint-Dié-des-Vosges
88100
France

Phone +33 (0) 608423941
Email jean-marc-dollet@wanadoo.fr

Study information

Study designObservational cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleHigh frequency of abnormal glucose tolerance in Senegalese migrants: a new example of the heavy consequences of the nutritional transition
Study acronymDiabetes SD/F
Study objectivesSenegalese migrants have a higher risk of developing diabetes mellitus than their relatives remaining in their birth country. The main reason seems to be the nutritional transition (diet and sedentarity).

We compared the prevalence of abnormal glucose status between Senegalese migrants and their relatives staying in their villages in Fuuta (a region in the Northern part of Senegal).
Ethics approval(s)Ethics Commitee of Centre Hospitalier Saint-Charles à Saint-Dié-des-Vosges, June 2000
Health condition(s) or problem(s) studiedDiabetes, migration, public health
InterventionStudy on Senegalese adults living in Saint-Die (France) and a representative sample of their relatives in five villages in Fuuta (Senegal). For all the selected subjects we measured four anthropometric parameters (height, weight, BMI and waist/hip ratio) and fasting capillary glycaemia. We stay for one day in each village.
Intervention typeOther
Primary outcome measure1. Anthropometric measures (height, weight, BMI and waist/hip ratio)
2. Blood capillary glucose, measured using a Glucotrend device (Lab. Boehringer)

All of the measures were taken at baseline in one day.
Secondary outcome measuresN/A
Overall study start date01/11/2000
Completion date01/11/2001

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants50 in Saint-Die (France); 1000 in Fuuta (Senegal)
Key inclusion criteria1. All Senegalese migrants living in Saint-Die (France)
2. A representative sample of their relatives in five villages in Fuuta (Senegal)
3. Adults between 18 and 75 years
Key exclusion criteria1. Pregnancy
2. Illness
Date of first enrolment01/11/2000
Date of final enrolment01/11/2001

Locations

Countries of recruitment

  • France
  • Senegal

Study participating centre

Service de Médecine A
Saint-Dié-des-Vosges
88100
France

Sponsor information

Centre Hospitalier Saint-Charles à Saint-Dié-des-Vosges (France)
Hospital/treatment centre

c/o Dr Jean-Marc Dollet
Service de Médecine A
Centre Hospitalier Saint-Charles
Saint-Dié-des-Vosges
88100
France

Website http://www.centrehospitalierdesaintdiedesvosges.com/
ROR logo "ROR" https://ror.org/000tm9s39

Funders

Funder type

Hospital/treatment centre

Centre Hospitalier Saint-Charles à Saint-Dié-des-Vosges (France)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan